Comparative pathology of proliferative lesions of the urinary bladder

Toxicologic Pathology

Volumn 30, Issue 6, 2002, Pages 663-671

  Cohen, Samuel M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Bladder; Carcinoma; Dysplasia; Hyperplasia; Papilloma; Pathology; Urothelium

Indexed keywords

ANIMAL TISSUE; BLADDER CANCER; BLADDER CARCINOGENESIS; BLADDER DISEASE; CANCER INVASION; CELL PROLIFERATION; CONFERENCE PAPER; CYSTITIS; DYSPLASIA; HUMAN; HUMAN TISSUE; HYPERPLASIA; KIDNEY PELVIS; METASTASIS; NONHUMAN; PAPILLOMA; PATHOLOGY; PRIORITY JOURNAL; RAT; URETHRA; UROTHELIUM;

ADENOCARCINOMA; ANIMALS; HUMANS; HYPERPLASIA; MICE; MICROSCOPY, ELECTRON, SCANNING; PAPILLOMA; PRECANCEROUS CONDITIONS; RATS; SPECIES SPECIFICITY; URINARY BLADDER NEOPLASMS; UROTHELIUM;

ANIMALIA; RODENTIA;

EID: 0036866771     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230290166751     Document Type: Conference Paper

References (47)

1. Johansson SL, Cohen SM (1996). Lower urinary tract. In: Anderson's Pathology, Vol 2, Damjanov I, Linder J (eds). Mosby, New York, pp 2143-2165.
2. Cohen SM (1983). Pathology of experimental bladder cancer in rodents. In: The Pathology of Bladder Cancer, Vol II, Cohen SM, Bryan GT (eds). CRC Press, Boca Raton, FL, pp 1-40.
3. Droller MJ (1998). Bladder cancer: State of the art care. CA-A Cancer J For Clin 48: 269-284.
4. Spruck CH III, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmutte C, Yang AS, Cote R, Dubeau L, Nichols PW, Hermann GG, Steven K, Horn T, Skinner DG, Jones PA (1994). Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54: 784-788.
5. Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998). Bladder consensus conference committee: The World Health Organization/International Society of Urologic Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22: 1435-1448.
6. Cordon-Cardo C, Shenfeld J, Dalbagni G (1997). Genetic studies and molecular markers of bladder cancer. Sem Surg Oncol 13: 319-327.
7. Shirai T, Fukushima S, Hirose M, Ohshima M, Ito N (1987). Epithelial lesions of the urinary bladder in three hundred and thirteen autopsy cases. Jpn J Cancer Res 78: 1073-1080.
8. Wiener DP, Koss LG, Sablay B, Freed SZ (1979). The prevalence and significance of Brunn's nests, cystitis cystica and squamous metaplasia in normal bladders. J Urol 122: 317-321.
9. Ito N, Fukushima S (1986). Carcinogenesis, urinary tract, rat. In: Urinary System, Jones TC, Mohr U, Hunt RD (eds). Springer-Verlag, Berlin, pp 17-322.
10. Kunze E, Schauer A, Schatt S (1976). Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of rats. Z Krebsforsch 87: 139-160.
11. Fukushima S, Arai M, Cohen SM, Jacobs JB, Friedell GH (1981). Scanning electron microscopy of cyclophosphamide-induced hyperplasia of the rat urinary bladder. Lab Invest 44: 89-96.
12. Fukushima S, Cohen SM, Arai M, Jacobs JB, Friedell GH (1981). Scanning electron microscopic examination of reversible hyperplasia of the rat urinary bladder. Am J Pathol 102: 373-380.
13. Shirai T, Ikawa E, Fukushima S, Masui T, Ito N (1986). Uracil-induced urolithiasis and the development of reversible papillomatosis in the urinary bladder of F344 rats. Cancer Res 46: 2062-2067.
14. Sakata T, Masui T, St. John M, Cohen SM (1988). Uracil-induced caculi and proliferative lesions of the mouse urinary bladder. Carcinogenesis 9: 1271-1276.
15. 1, mice as a useful model for study of chemoprevention of cancer with retinoids. Cancer Res 41: 927-932.
16. 1 mice. Mol Carcinogenesis 21: 270-279.
17. Asamoto M, Mann AM, Cohen SM (1994). p53 mutation is infrequent and might not give a growth advantage in rat bladder carcinogenesis in vivo. Carcinogenesis 15: 455-458.
18. Masui T, Don I, Takada N, Ogawa K, Shirai T, Fukushima S (1994). p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine. Carcinogenesis 15: 2379- 2381.
19. Jacobs JB, Cohen SM, Arai M, Friedell GH, Bulay O, Urman HK (1976). Chemically induced smooth muscle tumors of the mouse urinary bladder. Cancer Res 36: 2396-2398.
20. Halliwell W (in press). Proliferative mesenchymal lesions (submucosal mesenchymal tumor) of the urinary bladder. Env Hlth Persp.
21. Arnold LL, Christenson R, Cano M, St. John MK, Wahl BS, Cohen SM (1997). Tributyl phosphate effects on urine and bladder epithelium in male Sprague-Dawley rats. Fund Applied Toxicol 40: 247-255.
22. Cohen SM (1998). Cell proliferation and carcinogenesis. Drug Met Rev 30: 339-357.
23. Clayson DB, Fishbein L, Cohen SM (1995). The effect of stones and other physical factors on the induction of rodent bladder cancer. Fd Chem Toxicol 33: 771-784.
24. Engelmann U, Schramek P, Baum HP, Wertmann B, Grun M, Jacobi GH (1987). Bladder carcinogenesis in portacaval shunt rats. Urol Int 42: 165-169.
25. Jull JW (1979). The effect of time on the incidence of carcinomas obtained by the implantation of paraffin wax pellets into mouse bladder. Cancer Lett 6: 21-25.
26. Cohen SM (1995). The role of urinary physiology and chemistry in bladder carcinogenesis. Fd Chem Toxicol 33: 715-730.
27. Burin GJ, Gibb HJ, Hill RN (1995). Human bladder cancer: Evidence for a potential irritation-induced mechanism. Fd Chem Toxicol 33: 785-795.
28. Rodent Bladder Carcinogenesis Working Group (1995). Urinary bladder carcinogenesis: Implications for risk assessment. Fd Chem Toxicol 33: 797-802.
29. Cohen SM, Fisher MJ, Sakata T, Cano M, Schoenig GP, Chappel CI, Garland EM (1990). Comparative analysis of the proliferative response of the rat urinary bladder to sodium saccharin by light and scanning electron microscopy and autoradiography. Scan Microsc 4: 135-142.
30. Smith RA, Christenson WR, Bartels MJ, Arnold LL, St. John MK, Cano M, Wahle BS, McNett DA, Cohen SM (1998). Urinary physiologic and chemical metabolic effects on the urothelial cytotoxicity and potential genotoxicity of o-phenylphenol in male rats. Toxicol Appl Pharmacol 150: 402-413.
31. Cohen SM (1999). Calcium phosphate-containing urinary precipitate in rat urinary bladder carcinogenesis. International Agency for Research on Cancer, Lyon, France, IARC Sci Publ 147: 175-189.
32. Ellwein LB, Cohen SM (1990). The health risks of sacchharin revisited. Crit Rev Toxicol 20: 311-326.
33. Pauli BU, Alroy J, Weinstein RS (1983). The ultrastructure and pathobiology of urinary bladder cancer. In: The Pathology of Bladder Cancer, Vol II, Cohen SM, Bryan GT (eds). CRC Press, Boca Raton, FL, pp 41-140.
34. Wu XR, Lin JH, Walz T, Haner M, Yu J, Aebi U, Sun TT (1994). Mammalian uroplakins. J Biol Chem 269: 13716-13724.
35. Ogawa K, Sun T-T, Cohen SM (1996). Analysis of differentiation-associated proteins in rat bladder carcinogenesis. Carcinogenesis 17: 961-965.
36. Johansson SL, Cohen SM (1997). Epidemiology and etiology of bladder cancer. Sem Surg Oncol 13: 291-298.
37. El-Bolkainy MN (1983). Schistosomiasis and bladder cancer. In: The Pathology of Bladder Cancer, Vol I, Cohen SM, Bryan GT (eds). CRC Press, Boca Raton, FL, pp 57-89.
38. Steineck G, Plato N, Alfredsson L, Norell SE (1989). Industry-related urothelial carcinogens: Application of a job-exposure matrix to census data. Am J Ind Med 16: 209-224.
39. Birt DF, Julius AD, Hasegawa R, St. John MS, Cohen SM (1987). Effect of L-tryptophan excess and vitamin B6 deficiency on urinary bladder cancer promotion. Cancer Res 47: 1244-1250.
40. IARC Working Group (1999). Consensus Report. International Agency for Research on Cancer, Lyon, France, IARC Scientific Publications 147: 1-32.
41. 9th Report on Carcinogens (2000). U.S. Department of Health and Human Services, National Toxicology Program, Research Triangle Park, NC, pp B3-B4.
42. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (1999). Some chemicals that cause tumours of the kidney or urinary bladder in rodents and some other substances. International Agency for Research on Cancer, Lyon, France, 73:516-624.
43. Cohen SM, Ellwein LB (1990). Cell proliferation in carcinogenesis. Science 249:1007-1011.
44. Cohen SM (1998). Urinary bladder carcinogenesis. Toxicol Pathol 26: 121-127.
45. US Environmental Protection Agency (1997). Report on the Expert Panel on Arsenic Carcinogenicity. National Center for Environmental Assessment, US Environmental Protection Agency, Washington, DC.
46. Arnold LL, Cano M, St. John MK, Eldan M, van Gemert M, Cohen SM (1999). Effects of dietary dimethylarsinic acid on the urine and urothelium of rats. Carcinogenesis 20: 101-109.
47. Cohen SM, Cano M, Johnson LS, St. John MK, Asamoto M, Garland EM, Thyssen JH, Sangha GK, Van Goethem DL (1994). Mitogenic effects of propoxur on male rat bladder urothelium. Carcinogenesis 15: 2593-2597.